(Q73835143)
Statements
A dose-ranging study of the efficacy and safety of tamsulosin, the first prostate-selective alpha 1A-adrenoceptor antagonist, in patients with benign prostatic obstruction (symptomatic benign prostatic hyperplasia) (English)
P Abrams
M Speakman
M Stott
D Arkell